The Other Deadness

Price Rationale

I weight the liquidity, cultural, and cycle appraisals above the broad comparable-sales mark. The 115 ETH comparable value relies on stronger universe anchors without enough same-token proof; the 38-40 ETH marks are disciplined on exit risk but understate the 2020 1/1 premium over the 33.95 ETH 2025 sale of the related 25-owner The Deadness edition. With no target sale, ask, bid, OTC print, or grail flag, 58 ETH is a cautious fair value: meaningfully above the edition lineage context and stale low 2020 sales, but below cleaner recent non-grail 1/1 anchors with direct market evidence.

What Caps The Price

Not higher because the target has zero direct sale history, no live bid or ask, no OTC support, no grail flag, and a source audit anomaly. The only supplied candidate is explicitly lineage context, not a peer. Paying 90-115+ ETH would require assuming broader 1/1 universe anchors transfer cleanly despite weaker public-standing evidence and untested exit demand.

What Supports The Price

Not lower because this remains an early XCOPY single-supply work with a canonical record and recognizable Deadness-family linkage. The 33.95 ETH 2025 edition sale is not a ceiling for a 1/1 branch, and recent non-grail XCOPY 1/1 evidence shows credible demand above pure edition or distressed-liquidity levels.